You are here
New AAN Guideline on Treatment of Chorea in Huntington’s Disease
Huntington’s disease is a complex disorder with physical, cognitive, and behavioral symptoms. The new guideline addresses only one aspect of the disease that may require treatment.
“Chorea can be disabling, worsen weight loss, and increase the risk of falling,” said Melissa Armstrong, MD, MSc, the guideline’s lead author. According to the new statement, tetrabenazine (TBZ), riluzole, and amantadine may be helpful for treating chorea, and nabilone may also be considered. Riluzole, amantadine, and nabilone are not often prescribed for Huntington’s disease.
“People with Huntington’s disease who have chorea should discuss with their doctors whether treating chorea is a priority,” Dr. Armstrong said “Huntington’s disease is complex, with a wide range of sometimes severe symptoms, and treating other symptoms may be a higher priority than treating chorea.”